| Target Price | HK$9.99 |
| Price | HK$6.02 |
| Potential |
66.10%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Jacobio Pharmaceuticals Grou 2027 .
The average Jacobio Pharmaceuticals Grou target price is HK$9.99.
This is
66.10%
register free of charge
HK$10.86
80.50%
register free of charge
HK$9.34
55.32%
register free of charge
|
|
| A rating was issued by 8 analysts: 6 Analysts recommend Jacobio Pharmaceuticals Grou to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Jacobio Pharmaceuticals Grou stock has an average upside potential 2027 of
66.10%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million HK$ | 62.65 | 914.86 |
| 65.62% | 1,360.27% | |
| EBITDA Margin | -267.96% | 52.72% |
| 134.82% | 119.67% | |
| Net Margin | -272.72% | 63.79% |
| 172.72% | 123.39% |
4 Analysts have issued a sales forecast Jacobio Pharmaceuticals Grou 2026 . The average Jacobio Pharmaceuticals Grou sales estimate is
This results in the following potential growth metrics:
4 Jacobio Pharmaceuticals Grou Analysts have issued a net profit forecast 2026. The average Jacobio Pharmaceuticals Grou net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share HK$ | -0.22 | 0.75 |
| 8.33% | 440.91% | |
| P/E | 8.06 | |
| EV/Sales | 3.27 |
4 Analysts have issued a Jacobio Pharmaceuticals Grou forecast for earnings per share. The average Jacobio Pharmaceuticals Grou EPS is
This results in the following potential growth metrics and future valuations:
Jacobio Pharmaceuticals Grou...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


